ArticleJournal for immunotherapy of cancer2024

Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus.

Stefan Barisic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.